TY - JOUR
T1 - Less Is More
T2 - A Minimalist Approach to Endoscopy
AU - Shaheen, Nicholas J.
AU - Fennerty, M. Brian
AU - Bergman, Jacques J.
N1 - Funding Information:
Conflicts of interest Nicholas J. Shaheen receives research funding from Medtronic, CSA Medical, C2 Therapeutics, Boston Scientific, and CDx Medical. M. Brian Fennerty serves on a Data Safety and Monitoring Board for C2 Therapeutics. Jacques J. Bergman receives research funding from Medtronic, C2 Therapeutics, CDx Medical, Fujifilm, Pentax Endoscopy, Fractyl Medical, Cernostics, Interpace, Boston Scientific, Erbe Medical, and NinePoint Medical; and also receives consultancy fees from Apollo.
Publisher Copyright:
© 2018 AGA Institute
PY - 2018/5
Y1 - 2018/5
N2 - A substantial literature documents inappropriate usage of gastrointestinal endoscopy in a variety of clinical settings. Overusage of endoscopy appears to be common, and 30% or more of procedures performed in some clinical settings have questionable indications. The potential reasons for overuse of endoscopy are multiple, and include cancer phobia, fear of medical malpractice litigation, profit motive, the investigation of “incidentalomas” found on other imaging, and underappreciation of the delayed harms of endoscopy, among other reasons. Clinical guidelines, which should limit overuse of endoscopy, may instead serve to promote it, if authors opt to be “conservative,” recommending endoscopy in situations of unclear utility. Several strategies may decrease overuse of endoscopy, including careful attention to risk stratification when choosing patients to screen, adherence to guidelines for surveillance intervals for colonoscopy, the use of quality indicators to identify outliers in endoscopy utilization, and education on appropriate indications and the risks of overuse at the medical student, residency, and fellowship levels.
AB - A substantial literature documents inappropriate usage of gastrointestinal endoscopy in a variety of clinical settings. Overusage of endoscopy appears to be common, and 30% or more of procedures performed in some clinical settings have questionable indications. The potential reasons for overuse of endoscopy are multiple, and include cancer phobia, fear of medical malpractice litigation, profit motive, the investigation of “incidentalomas” found on other imaging, and underappreciation of the delayed harms of endoscopy, among other reasons. Clinical guidelines, which should limit overuse of endoscopy, may instead serve to promote it, if authors opt to be “conservative,” recommending endoscopy in situations of unclear utility. Several strategies may decrease overuse of endoscopy, including careful attention to risk stratification when choosing patients to screen, adherence to guidelines for surveillance intervals for colonoscopy, the use of quality indicators to identify outliers in endoscopy utilization, and education on appropriate indications and the risks of overuse at the medical student, residency, and fellowship levels.
KW - Barrett's Esophagus
KW - Colorectal Cancer Screening
KW - Gastrointestinal Endoscopy
KW - Utilization
UR - http://www.scopus.com/inward/record.url?scp=85046773696&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046773696&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2017.12.044
DO - 10.1053/j.gastro.2017.12.044
M3 - Article
C2 - 29454789
AN - SCOPUS:85046773696
SN - 0016-5085
VL - 154
SP - 1993
EP - 2003
JO - Gastroenterology
JF - Gastroenterology
IS - 7
ER -